Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Velcade
Related studies linked through entity extraction aliases.
Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates
- Status
- COMPLETED
- Phase
- PHASE2
PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
- Status
- TERMINATED
- Phase
- PHASE2
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
UARK 2003-33, Total Therapy III
- Status
- COMPLETED
- Phase
- PHASE2